Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Array Technologies, Inc. Stock Price (Quote) NASDAQ:ARRY
$9.07 ( 0.67% ) Friday, 20th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $5.45 | $9.60 | Friday, 20th May 2022 ARRY stock ended at $9.07. This is 0.67% more than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 10.66% from a day low at $8.68 to a day high of $9.60. |
| 90 days | $5.45 | $13.96 | |
| 52 weeks | $5.45 | $27.67 |
Historical Array Technologies, Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-20 | $9.05 | $9.60 | $8.68 | $9.07 | 5 356 133 |
| 2022-05-19 | $8.34 | $9.16 | $8.26 | $9.01 | 5 113 379 |
| 2022-05-18 | $7.75 | $9.23 | $7.74 | $8.50 | 8 144 526 |
| 2022-05-17 | $7.13 | $7.94 | $7.02 | $7.91 | 5 842 167 |
| 2022-05-16 | $7.07 | $7.37 | $6.62 | $6.93 | 6 527 922 |
| 2022-05-13 | $6.57 | $7.41 | $6.43 | $7.08 | 7 632 660 |
| 2022-05-12 | $6.16 | $6.54 | $5.45 | $6.20 | 10 060 025 |
| 2022-05-11 | $6.18 | $7.39 | $6.17 | $6.42 | 10 202 360 |
| 2022-05-10 | $7.66 | $7.67 | $6.49 | $6.92 | 10 116 485 |
| 2022-05-09 | $8.57 | $8.63 | $7.14 | $7.31 | 6 506 835 |
| 2022-05-06 | $9.11 | $9.21 | $8.35 | $8.87 | 6 978 519 |
| 2022-05-05 | $9.05 | $9.19 | $8.55 | $9.16 | 4 996 099 |
| 2022-05-04 | $8.26 | $9.33 | $8.13 | $9.25 | 6 474 987 |
| 2022-05-03 | $7.20 | $8.32 | $7.07 | $8.24 | 6 427 654 |
| 2022-05-02 | $6.52 | $7.40 | $6.44 | $7.21 | 6 753 570 |
| 2022-04-29 | $6.77 | $7.04 | $6.49 | $6.53 | 3 101 442 |
| 2022-04-28 | $6.79 | $7.12 | $6.31 | $6.80 | 5 825 532 |
| 2022-04-27 | $6.66 | $7.21 | $6.65 | $6.74 | 4 836 275 |
| 2022-04-26 | $7.01 | $7.17 | $6.73 | $6.82 | 5 440 370 |
| 2022-04-25 | $6.86 | $7.18 | $6.60 | $7.13 | 5 356 509 |
| 2022-04-22 | $7.07 | $7.14 | $6.97 | $7.00 | 2 270 418 |
| 2022-04-21 | $8.62 | $8.68 | $7.17 | $7.39 | 11 470 500 |
| 2022-04-20 | $9.19 | $9.38 | $8.49 | $8.49 | 4 216 800 |
| 2022-04-19 | $8.44 | $9.28 | $8.26 | $9.14 | 4 512 000 |
| 2022-04-18 | $8.67 | $8.75 | $8.35 | $8.52 | 2 752 200 |
| 2022-04-14 | $8.90 | $8.90 | $8.72 | $8.73 | 2 900 772 |
| 2022-04-13 | $9.18 | $9.32 | $8.97 | $9.18 | 4 399 224 |
| 2022-04-12 | $9.51 | $9.83 | $9.24 | $9.26 | 4 287 111 |
| 2022-04-11 | $9.17 | $9.87 | $9.09 | $9.47 | 4 008 490 |
| 2022-04-08 | $10.18 | $10.28 | $9.27 | $9.28 | 5 516 142 |
| 2022-04-07 | $11.00 | $11.13 | $10.15 | $10.41 | 4 833 400 |
| 2022-04-06 | $12.48 | $12.66 | $10.56 | $11.03 | 12 668 100 |
| 2022-04-05 | $11.94 | $12.17 | $10.44 | $10.57 | 6 384 200 |
| 2022-04-04 | $11.03 | $12.75 | $11.03 | $11.92 | 5 942 200 |
| 2022-04-01 | $11.30 | $11.68 | $10.92 | $10.95 | 3 285 888 |
| 2022-03-31 | $11.30 | $11.81 | $11.04 | $11.27 | 3 564 943 |
| 2022-03-30 | $12.22 | $12.28 | $11.26 | $11.29 | 3 658 941 |
| 2022-03-29 | $12.30 | $12.56 | $11.78 | $12.28 | 4 194 700 |
| 2022-03-28 | $12.87 | $13.22 | $11.69 | $12.24 | 4 474 700 |
| 2022-03-25 | $13.59 | $13.60 | $12.60 | $13.06 | 3 970 400 |
| 2022-03-24 | $13.51 | $13.78 | $13.19 | $13.65 | 1 691 600 |
| 2022-03-23 | $13.10 | $13.70 | $12.55 | $13.33 | 1 901 300 |
| 2022-03-22 | $13.30 | $13.96 | $13.18 | $13.32 | 2 743 085 |
| 2022-03-21 | $12.97 | $13.59 | $12.73 | $13.29 | 4 022 520 |
| 2022-03-18 | $12.29 | $13.21 | $12.11 | $13.14 | 5 732 929 |
| 2022-03-17 | $11.98 | $12.58 | $11.95 | $12.53 | 3 233 800 |
| 2022-03-16 | $10.98 | $11.84 | $10.72 | $11.80 | 3 514 200 |
| 2022-03-15 | $10.17 | $10.81 | $9.83 | $10.79 | 2 660 100 |
| 2022-03-14 | $10.58 | $10.77 | $10.09 | $10.20 | 1 951 300 |
| 2022-03-11 | $11.10 | $11.59 | $10.53 | $10.62 | 1 973 600 |
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The companys drugs in Phase III clinical trials include Binimetinib, Encorafenib, and Selumetinib for the treatment of cancer, as well as ASC08/Danoprevir, a protease inhibitor for hepatitis C virus. Its drug candidates in Phase II cl... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
